Tara Cumming, NP
Acute Care · San Antonio, TXNPI 1831632066
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Photocure Inc accounts for 86.0% of it on its own, with 15 other manufacturers making up the rest. Among acute care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $259.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Photocure Inc$10K
- Teleflex LLC$976
- Medtronic$182
- KARL Storz Endoscopy-america$78
- Sumitomo Pharma America, Inc.$72
- Johnson & Johnson$59
- plus $342 from 10 others
What the payments were for
- Consulting fees$1,72514%
- Speaking & faculty fees$5,73047%
- Travel & lodging$3,43428%
- Food & beverage$1,31511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Photocure Inc | 13 | $10,495 |
| Teleflex LLC | 13 | $976 |
| Medtronic | 2 | $182 |
| KARL Storz Endoscopy-america | 1 | $78 |
| Sumitomo Pharma America, Inc. | 3 | $72 |
| Johnson & Johnson | 2 | $59 |
| Astellas Pharma US Inc | 2 | $55 |
| Tolmar, Inc. | 2 | $44 |
| Antares Pharma, Inc. | 1 | $44 |
| Urogen Pharma, Inc. | 2 | $40 |
| Coloplast | 1 | $37 |
| 180 Medical, Inc. | 1 | $30 |
| Procept Biorobotics Corporation | 1 | $30 |
| Axonics, Inc. | 1 | $28 |
| Myovant Sciences Inc. | 1 | $19 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cysview$10,395
- UroLift System$703
- INTERSTIM$161
How this compares
$12,204 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 67 | $69,547 |
| GemtesaVibegron | 67 | $65,781 |
| Mirabegron ErMirabegron | 12 | $7,149 |
| Tamsulosin Hcl | 301 | $5,372 |
| Finasteride | 307 | $4,284 |
| Trospium Chloride ErTrospium Chloride | 16 | $3,707 |
| Estradiol | 29 | $2,078 |
| Solifenacin Succinate | 29 | $1,601 |
| Trospium Chloride | 29 | $1,033 |
| Tolterodine Tartrate ErTolterodine Tartrate | 15 | $1,000 |
| NitrofurantoinNitrofurantoin Macrocrystal | 28 | $997 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $789 |
| Dutasteride | 32 | $690 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 60 | $660 |
| Ciprofloxacin Hcl | 69 | $324 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $55 | $69,54767 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $72 | $65,78167 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,323 acute care providers in Texas.
Other acute care in San Antonio
- Christie MorrisonSan Antonio$225K
- Jessica BjerkSan Antonio$20K
- Erin HernandezSan Antonio$10K
- Daniel ChristensenSan Antonio$8K
- Jill FolkertSan Antonio$8K
- Jennifer PilotteDallas$232K
- Amanda BradleyDallas$85K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
- Martha LibertyDallas$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.